Cytokine expression of HIV-infected monocytes/macrophages at the single-cell level. 1994

W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
Georg-Speyer-Haus, Chemotherapeutisches Forschungsinstitut, Frankfurt am Main, Germany.

Monocytes of healthy donors were infected with HIV1 in vitro: 14-21 days after infection 50-70% of the cells produced p24 HIV1 antigen as detected with anti-p24 immunostaining; infected cultures showed enhanced secretion of interleukin-6 (IL6), interleukin-8 (IL8) and tumour necrosis factor alpha (TNF-alpha). The expression of cytokines on the single-cell level was further analysed by in situ hybridization using nonradioactive digoxigenin for detection. HIV1 (p24+) -producing cells were compared with non-HIV (p24-) -producing cells. All morphological subtypes of macrophages showed HIV production; no difference in cytokine expression was observed. Immunocytochemistry of HIV-infected and uninfected cultures also showed no difference in the pattern of IL1-beta, IL6, IL8 and TNF-alpha protein expression in the cells.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
March 1998, Kidney international,
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
January 1991, Research in virology,
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
May 1991, Cytokine,
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
May 1997, Journal of clinical immunology,
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
April 1998, European journal of immunology,
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
December 1967, The Australian journal of experimental biology and medical science,
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
September 1989, European journal of immunology,
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
March 1990, Journal of immunology (Baltimore, Md. : 1950),
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
January 1990, Disease markers,
W Glienke, and R Esser, and H von Briesen, and K Schuster, and S Müller, and R Unger, and R Andreesen, and H J Stutte, and H Rübsamen-Waigmann
December 2012, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Copied contents to your clipboard!